Cullinan Therapeutics, Inc. (CGEM)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
17. 69
+1.28
+7.8001%
$
1.09B Market Cap
- P/E Ratio
- Div Yield
594,700 Volume
- Eps
$ 16.41
Previous Close 
Want to track CGEM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
CGEM Earnings Reports FAQ
What is the earnings per share (EPS) for CGEM?
EPS data for CGEM is currently not available, as Cullinan Therapeutics, Inc has not reported recent earnings.
What is the company's earnings growth rate?
Cullinan Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Cullinan Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Cullinan Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for CGEM at this time, as Cullinan Therapeutics, Inc has no recent EPS data to calculate it.
